Welcome to the Working Group on New TB Drugs Blog
News from the TB Treatment Field
Recent articles from around the globe related to governments addressing problems with providing treatment services to those with tuberculosis
Stop TB Partnership’s Coordinating Board Meets in DC
Today was the opening of the 2-day Stop TB Partnership’s Coordinating Board (CB) meeting in Washington, D.C. which included welcoming remarks by Dr. Rajiv Shah (Administrator, USAID), Ms. Lois Quam (Executive Director, GHI), and Dr. Howard Koh (Assistant Secretary, U.S. Depart. of HHS).
Public Sector Has Significant Role in Drug Development
With government budget shortfalls and looming funding cuts, priorities across the public sector are being scrutinized especially with relation to scientific and medical research which represents only 2% of the total federal budget in the U.S. This month, two articles published in separate journals by different groups with different objectives address the role of the public sector in the development of pharmaceuticals. Both articles found that the public sector does have impact in this area especially for innovative drugs and biologics.
FDA Streamlines Review for Drug Combinations
The FDA issued a draft guidance for the drug industry entitled “Guidance for Industry Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination.” This is exciting news for TB drug development, since there is the potential to reduce the time to develop and obtain approval for new regimens by several years. The FDA is accepting comments from the public until February 14, 2011.
Duke Students Study TB Control in Rural North Carolina
“When I told my friends about my summer plans, many were surprised to hear that tuberculosis still existed in the US, not to mention, right here in North Carolina,” writes Duke University senior Catherine Castillo in her first blog post as an intern at the Wake County Tuberculosis Program.
Interview of TB Patient, Mr. R.
In June of this year, the WGND interviewed a patient in New Jersey who was being treated by the DOTS program of the Global Tuberculosis Institute at UMDNJ. While his point-of-view is by no means universal, it provides an oft-overlooked window into tuberculosis in the United States.
Posted in TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Interview with Dr. Lee Reichman – Part Three
This is part three of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.
Posted in TB Prevention and Control Strategies, Video, Voices from the Fight to Stop Tuberculosis
Interview with Dr. Lee Reichman – Part Two
This is part two of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.
-
Toppix TB News- Editorial: Lives at risk if the U.S. shortchanges Global Fund 4 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- WHO says TB in Russia displays highest known drug resistance 3 Feb 2012
- Media outlets examine Global Fund's future as it enters second decade 3 Feb 2012
